By Colin Kellaher

 

Humana Inc. (HUM) Monday said it agreed to buy Enclara Healthcare, a provider of hospice pharmacy and benefit management, for an undisclosed amount.

The Louisville, Ky., health insurer said Enclara serves more than 450 hospice providers and 97,000 hospice patients a day.

Humana said it expects to complete the acquisition, which includes Enclara Pharmacia, GuidantRx and Avanti Health Care Services, during the first half of 2020, adding that it expects no material impact to earnings next year.

Humana is buying Enclara from New York private-equity firm Consonance Capital Partners and Enclara management. Consonance recapitalized Enclara in 2014 in the firm's first investment from its maiden fund.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

December 16, 2019 06:57 ET (11:57 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Humana (NYSE:HUM)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Humana Charts.
Humana (NYSE:HUM)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Humana Charts.